SMS Pharmaceuticals Ltd — Capital/Financing Update 2025

Dec 26, 2025

==> picture [241 x 158] intentionally omitted <==

Date: 26[th] December, 2025

To The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001. Mumbai - 400 051.

Security Code: 532815 Symbol: SMSPHARMA

Dear Sir/Madam,

Subject: Intimation under Regulation 30 read with Schedule III of SEBI LODR Regulations, 2015 - Investments in Subsidiary Company by way of subscription towards Rights Issue

In terms of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform that the Subsidiary Company “SMS Peptides Private Limited” has allotted 39,90,000 equity shares of Rs. 10/- each amounting to Rs. 3,99,00,000/-, to the Company. Pursuant to this the holding of the Company in its Subsidiary has been increased from 99.98% to 99.99% of the equity share capital of SMS Peptides Private Limited.

The disclosure as required under Schedule III of the Listing Regulations read with SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 November 11, 2024 is enclosed as Annexure-1 to this letter.

This is for your information and records.

Thanking you Yours faithfully

For SMS Pharmaceuticals Limited

THIRUMALES Digitally signed by THIRUMALESH TUMMA H TUMMA Date: 2025.12.26 18:23:54 +05'30' Thirumalesh Tumma Company Secretary

Annexure – 1

Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

Sr. No.	Particulars	Details
1.	Name of the target entity, details in brief such as size, turnover etc.,	M/s. SMS Peptides Private Limited (SMS Peptides), Subsidiary Company, incorporated under Companies Act, 2013. Authorised Share Capital of the Company is Rs.10,00,00,000/- divided into 1,00,00,000 equity shares of Rs.10/- each and the paid-up share capital of the Company is Rs.7,00,00,000/- divided into 70,00,000 equity shares of Rs.10/- each.
2.	Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length”	Yes, since SMS peptides is a subsidiary Company of SMS Pharmaceuticals Limited and would fall within the purview of related party transaction in terms of SEBI (LODR) Regulations, 2015. The Company’s interest is limited only to the extent of its shareholding The said transaction is at arm's length.
3.	industry to which the entity being acquired belongs	SMS Peptides belongs to Pharmaceutical Industry.

4.	objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity	To procure machinery and equipment to carry on R&D activities related to the Subsidiary Company
5.	brief details of any governmental or regulatory approvals required for the acquisition	None
6.	indicative time period for completion of the acquisition	The subsidiary company allotted 39,90,000 equity shares of Rs.10/- each on 26.12.2025
7.	consideration - whether cash consideration or share swap or any other form and details of the same	Cash
8.	cost of acquisition and/or the price at which the shares are acquired	Cost of acquisition : Rs.3,99,00,000/- Share price : Rs.10/- each at par.
9.	Percentage of shareholding / control acquired and / or number of shares acquired:	SMS Pharmaceuticals Limited was holding 99.98% stake in SMS Peptides and after this investment the percentage is increased to 99.99%.
10.	brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)	SMS Peptides is a subsidiary Company incorporated in November, 2024. The company has not started revenue operations and is presently in the implementation stage. Date of Incorporation: 01st November, 2024 Country in which the acquired entity has presence: India Last 3 years turnover: From 01.11.2024 to 31.03.2025 :NIL